Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2003
11/19/2003EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/19/2003EP0991624B1 Phenylalkyl derivatives with thrombin-inhibiting effect
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0914111B1 Prevention and treatment of cachexia and anorexia
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003CN1457257A Extended native chemical ligation
11/19/2003CN1456561A Preparations of leucovorin and its carbonates
11/19/2003CN1456287A Preparation of Zengkangning tablets against leukopenia
11/19/2003CN1456263A Fresh motherwort juice-oral liquid preparing method
11/19/2003CN1456257A Fresh motherwort particle preparing method
11/19/2003CN1456256A Compound pseudo-ginseng preparing method
11/19/2003CN1456254A Preparation of immunoregulation effervescent tablets
11/19/2003CN1456253A Fresh motherwort tablet preparing method
11/19/2003CN1456251A Fresh motherwort pulp preparing method
11/19/2003CN1456229A Preparation of donkey hide gelatin effervescent granules for nourishing blood
11/19/2003CN1456198A Angong hemostatics
11/19/2003CN1456196A Yunnan Hongyao extractives and application thereof
11/19/2003CN1456173A High-efficiency fast styptic
11/19/2003CN1456163A Oral medicine of leucovocin calcium and its preparing method
11/19/2003CN1456162A Injection of leucovorin calcium and its preparing method
11/19/2003CN1456154A Method for curing sepsis
11/19/2003CN1127983C Inmunization adjusting anti-inflamation agent
11/18/2003US6649640 Isoxazole compositions useful as inhibitors of ERK
11/18/2003US6649636 Cyclooxygenase inhibitors
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649616 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia
11/18/2003US6649613 Diacylhydrazine derivatives
11/18/2003US6649604 Analgesics; antidiabetic agents; antiinflamamtory agents
11/18/2003US6649600 2,6-Dioxo or dithioxy-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo derivatives; highly potent and selective diuretics
11/18/2003US6649388 Polypeptides derived from JNK3
11/18/2003US6649386 Stability; for reconstitution with water; antihemophilic factor; blood factor IX
11/18/2003US6649375 Adenoviral vectors for enhanced gene expression
11/18/2003US6649339 Screening for the presence of a parvovirus genome equivalent using nucleic acid amplification; purification
11/18/2003US6649172 5-(p-carboxybenzyloxy)-2-oxybenzaldehyde derivatives; vaccine adjuvants
11/18/2003CA1341447C Mutant t-pa with kringle replacement
11/18/2003CA1341446C Tissue plasminogen activator analogs having modified growth factor domains
11/17/2003CA2429097A1 Composition of solutions for organ protection
11/14/2003CA2428516A1 Slowly digestible starch product
11/13/2003WO2003093465A1 FACTOR VII OR VIIa POLYPEPTIDE VARIANTS
11/13/2003WO2003093422A2 Novel tissue factor targeted antibodies as anticoagulants
11/13/2003WO2003093313A2 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
11/13/2003WO2003093297A2 Protein kinase modulators and methods of use
11/13/2003WO2003093254A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003WO2003093248A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003093235A1 Carboxylic acid amides
11/13/2003WO2003093234A1 Melanocortin receptor ligands
11/13/2003WO2003092767A2 A method for inhibiting platelet aggregation
11/13/2003WO2003092741A1 Delivery of microparticle-conjugated drugs for inhibition of stenosis
11/13/2003WO2003092740A1 Non-viral gene delivery system
11/13/2003WO2003092731A1 Stabilised solid compositions of modified factor vii
11/13/2003WO2003092721A1 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
11/13/2003WO2003092720A1 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
11/13/2003WO2003092715A2 Proteins involved in the regulation of energy homeostasis
11/13/2003WO2003092690A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003WO2003092673A1 Use of epa and dha in secondary prevention
11/13/2003WO2003092660A1 Monocompartment osmotic controlled drug delivery system
11/13/2003WO2003092605A2 Protease inhibitors
11/13/2003WO2003092602A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003WO2003092588A2 4-azasteroid derivatives as androgen receptor modulators
11/13/2003WO2003053966A3 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
11/13/2003WO2003042113A8 Production of cell suspensions
11/13/2003WO2003031407A3 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
11/13/2003WO2003030944A3 Inhibition of stat-1
11/13/2003WO2003012111A3 Conjugates for the modulation of immune responses
11/13/2003WO2003010281A3 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
11/13/2003WO2003009778A3 Methods and devices for delivery of therapeutic capable agents with variable release profile
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002067956A3 Method for purifying a biological composition
11/13/2003WO2002066648A3 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof
11/13/2003WO2002057226A8 68730 and 69112 protein kinase molecules and uses therefor
11/13/2003US20030212266 Growth arrest homeobox gene
11/13/2003US20030212141 Serotonin antagonists
11/13/2003US20030212138 Synergistic mixture; analgesics, antiinflammatory agents, cardiovascular disorders, anticancer agents
11/13/2003US20030212117 Efficient process for the preparation of a factor Xa inhibitor
11/13/2003US20030212093 Imidazonaphthyridines
11/13/2003US20030212091 Aryl ether substituted imidazoquinolines
11/13/2003US20030212073 Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
11/13/2003US20030212071 Controlling blood coagulation
11/13/2003US20030212069 Antithrombotic amides
11/13/2003US20030212064 Triazolotriazinones and the use thereof
11/13/2003US20030212054 Therapy, prevention thrombosis; anticoagulant
11/13/2003US20030212042 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
11/13/2003US20030212030 Blood disorders; synergistic mixture of vector and monoclonal antibody
11/13/2003US20030212012 Prevention labor contraction; urogenital disorders
11/13/2003US20030211986 Protein a compositions and methods of use
11/13/2003US20030211969 Administering activated protein c; controlling blood coagulation
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211103 Use of primate IFN-gamma binding molecules
11/13/2003US20030211077 Stimulanting hematopoiesis
11/13/2003CA2491708A1 Non-viral gene delivery system
11/13/2003CA2485116A1 Use of epa and dha in secondary prevention
11/13/2003CA2485086A1 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
11/13/2003CA2485065A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003CA2484874A1 Monocompartment osmotic controlled drug delivery system
11/13/2003CA2484551A1 Smart pro-drugs of serine protease inhibitors
11/13/2003CA2484209A1 Protein kinase modulators and methods of use
11/13/2003CA2484173A1 4-azasteroid derivatives as androgen receptor modulators